ResearcherZhongda Hospital Southeast UniversityNo recent work listed

Dafang Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1809-4829; OpenAlex author ID A5083492196. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 2 papers

Papers 2

Knockdown of hsa_circ_0074298 suppressed the progression of pancreatic cancer by targeting the miR-519/SMOC2 axis First author DOI 10.21203/rs.2.23308/v4 ↗
Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis. Co-author DOI 10.3892/ijo.2019.4937 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiahua Zhou · 2 shared papers, 2020 · strength 0.35
- Paper Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis. DOI 10.3892/ijo.2019.4937 ↗
- Paper Knockdown of hsa_circ_0074298 suppressed the progression of pancreatic cancer by targeting the miR-519/SMOC2 axis DOI 10.21203/rs.2.23308/v4 ↗
Hong Chen · 1 shared paper, 2020 · strength 0.16
- Paper Knockdown of hsa_circ_0074298 suppressed the progression of pancreatic cancer by targeting the miR-519/SMOC2 axis DOI 10.21203/rs.2.23308/v4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.